Organization | Karl Bremer Hospital, Cape Town South Africa

Karl Bremer Hospital, Cape Town South Africa Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Cape Town South Africa (1956)

Organization Overview

First Clinical Trial

2009

NCT00944021

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2012

Timeline

NOW

Now

Alternative names

Karl Bremer Hospital | Karl Bremer Hospital, Cape Town South africa | M2 Karl Bremer Hospital

Active Ingredients

Drugs in Phase 3 Trials (1)

Tuberculin, Purified Protein Derivative (Tubersol) (1 trial)

Drugs in Phase 2 Trials (5)

bedaquiline (sirturo) (2 trials)

clofazimine (lamprene) (1 trial)

moxifloxacin (avelox) (1 trial)

pretomanid (3 trials)

pyrazinamide (Aldinamide) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 4
# of Trial APIs: 6